Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Biological Psychiatry
|
December 1, 1983
Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia
P J Goodnick, C Tong, M B Duncavage, et al.
The Journal of Clinical Psychiatry
|
August 24, 1999
Mirtazapine in major depression with comorbid generalized anxiety disorder
P J Goodnick, A Puig, C L DeVane, et al.
International Pharmacopsychiatry
|
January 1, 1982
Lithium pharmacokinetics, duration of therapy, and the adenylate cyclase system
P J Goodnick, R R Fieve, H L Meltzer, et al.
Biological Psychiatry
|
February 1, 1980
CSF AMP in primary affective disorder: effects of probenecid and tryptophan
P J Goodnick, J M Perel, D L Dunner, et al.
Psychiatry Research
|
October 1, 1979
Repression and reactivation of lithium efflux from erythrocytes
P J Goodnick, H L Meltzer, D L Dunner, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1981
Lithium elimination half-life and duration of therapy
P J Goodnick, R R Fieve, H L Meltzer, et al.
Journal of Clinical Psychopharmacology
|
February 1, 1982
Differences in lithium kinetics between bipolar and unipolar patients
P J Goodnick, H L Meltzer, R R Fieve, et al.
The American Journal of Psychiatry
|
April 1, 1982
Lithium and amino acids
P J Goodnick, H E Evans, D L Dunner, et al.
Psychosomatic Medicine
|
June 14, 2000
Sertraline in diabetic neuropathy: response and biology
P J Goodnick, L Mendosa, A Kumar, et al.
Biological Psychiatry
|
October 27, 1998
Bupropion slow-release response in depression: diagnosis and biochemistry
P J Goodnick, R A Dominguez, C L DeVane, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Biological Psychiatry
|
December 1, 1983
Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia
P J Goodnick, C Tong, M B Duncavage, et al.
The Journal of Clinical Psychiatry
|
August 24, 1999
Mirtazapine in major depression with comorbid generalized anxiety disorder
P J Goodnick, A Puig, C L DeVane, et al.
International Pharmacopsychiatry
|
January 1, 1982
Lithium pharmacokinetics, duration of therapy, and the adenylate cyclase system
P J Goodnick, R R Fieve, H L Meltzer, et al.
Biological Psychiatry
|
February 1, 1980
CSF AMP in primary affective disorder: effects of probenecid and tryptophan
P J Goodnick, J M Perel, D L Dunner, et al.
Psychiatry Research
|
October 1, 1979
Repression and reactivation of lithium efflux from erythrocytes
P J Goodnick, H L Meltzer, D L Dunner, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1981
Lithium elimination half-life and duration of therapy
P J Goodnick, R R Fieve, H L Meltzer, et al.
Journal of Clinical Psychopharmacology
|
February 1, 1982
Differences in lithium kinetics between bipolar and unipolar patients
P J Goodnick, H L Meltzer, R R Fieve, et al.
The American Journal of Psychiatry
|
April 1, 1982
Lithium and amino acids
P J Goodnick, H E Evans, D L Dunner, et al.
Psychosomatic Medicine
|
June 14, 2000
Sertraline in diabetic neuropathy: response and biology
P J Goodnick, L Mendosa, A Kumar, et al.
Biological Psychiatry
|
October 27, 1998
Bupropion slow-release response in depression: diagnosis and biochemistry
P J Goodnick, R A Dominguez, C L DeVane, et al.
Page
of 7